Study S002187
MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease: Effects Of Semaglutide Treatment
Registration
Registered primary outcomes
- Change in gingival index [Baseline, 6 months, 12 months]
- Change in probing depth [Baseline, 6 months, 12 months]
- Change in BOP (Bleeding on probing) [Baseline, 6 months, 12 months]
- Change in Plaque Index [Baseline, 6 months, 12 months]
- Change in Clinical Attachment Level (CAL) [Baseline, 6 months, 12 months]
- Change in Gingival Margin Position (GM) [Baseline, 6 months, 12 months]
- Number of participants with Supragingival and Subgingival Calculus [Baseline, 6 months, 12 months]
- Change in Gingival Crevicular Fluid (GCF) [Baseline, 6 months, 12 months]
- Change in Bacterial Subgingival Biofilm [Baseline, 6 months, 12 months]
- Change in levels of Interleukin-1 beta (IL-1β) [Baseline, 6 months, 12 months]
- Change in levels of Tumor Necrosis Factor-alpha [Baseline, 6 months, 12 months]
- Change in levels of Interleukin-6 (IL-6) [Baseline, 6 months, 12 months]
- Change in levels of C-reactive protein (CRP) [Baseline, 6 months, 12 months]
- Change in levels of Soluble intercellular adhesion molecule-1 (sICAM-1) [Baseline, 6 months, 12 months]
- Change in levels of Soluble vascular cell adhesion molecule-1 (sVCAM-1) [Baseline, 6 months, 12 months]
- Change in levels of endocan [Baseline, 6 months, 12 months]
- Change in levels of Vascular Endothelial Growth Factor A (VEGF-A) [Baseline, 6 months, 12 months]
- Change in Oral Microbiome [Baseline, 6 months, 12 months]
- Change in active oral microbiome (RNA sequencing) [Baseline, 6 months, 12 months]
Linked records (0)
Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.
No records link to this registration yet.